Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Tyagi

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|March 25, 2020
Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse ModelDeepak V Almeida, Paul J Converse, Till F Omansen, et al.
The Journal of Infectious Diseases|October 17, 2006
Deletion of a Mycobacterium tuberculosis proteasomal ATPase homologue gene produces a slow-growing strain that persists in host tissuesGyanu Lamichhane, Tirumalai R Raghunand, Norman E Morrison, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis InfectionAmit Kaushik, Nicole C Ammerman, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2016
Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosisDeepak Almeida, Thomas Ioerger, Sandeep Tyagi, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2011
Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal modelsZahoor Ahmad, Mostafa M Fraig, Michael L Pinn, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosisEric Nuermberger, Ian Rosenthal, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|October 13, 2010
PA-824 exhibits time-dependent activity in a murine model of tuberculosisZahoor Ahmad, Charles A Peloquin, Rajendra P Singh, et al.
Plos Neglected Tropical Diseases|June 5, 2015
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans DiseasePaul J Converse, Sandeep Tyagi, Yalan Xing, et al.
The Journal of Infectious Diseases|October 30, 2008
Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous systemNicholas A Be, Gyanu Lamichhane, Jacques Grosset, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 2015
Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosisSandeep Tyagi, Nicole C Ammerman, Si-Yang Li, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|March 25, 2020
Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse ModelDeepak V Almeida, Paul J Converse, Till F Omansen, et al.
The Journal of Infectious Diseases|October 17, 2006
Deletion of a Mycobacterium tuberculosis proteasomal ATPase homologue gene produces a slow-growing strain that persists in host tissuesGyanu Lamichhane, Tirumalai R Raghunand, Norman E Morrison, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis InfectionAmit Kaushik, Nicole C Ammerman, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2016
Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosisDeepak Almeida, Thomas Ioerger, Sandeep Tyagi, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2011
Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal modelsZahoor Ahmad, Mostafa M Fraig, Michael L Pinn, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosisEric Nuermberger, Ian Rosenthal, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|October 13, 2010
PA-824 exhibits time-dependent activity in a murine model of tuberculosisZahoor Ahmad, Charles A Peloquin, Rajendra P Singh, et al.
Plos Neglected Tropical Diseases|June 5, 2015
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans DiseasePaul J Converse, Sandeep Tyagi, Yalan Xing, et al.
The Journal of Infectious Diseases|October 30, 2008
Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous systemNicholas A Be, Gyanu Lamichhane, Jacques Grosset, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 2015
Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosisSandeep Tyagi, Nicole C Ammerman, Si-Yang Li, et al.
Pageof 8